Management of Secondary Hyperparathyroidism Due to Nutritional Deficiencies

Pathophysiology and Diagnosis

Secondary hyperparathyroidism is characterized by normal or low serum calcium with elevated parathyroid hormone (PTH), commonly seen in vitamin D deficiency and malabsorption syndromes 1
Reduced plasma levels of 1,25(OH)₂D lead to decreased intestinal calcium absorption and impaired suppression of PTH synthesis 2

Measure serum 25-hydroxyvitamin D levels at first encounter to assess vitamin D status, and check corrected total calcium, phosphorus, and intact PTH levels, as recommended by the American Journal of Kidney Diseases 3
Assess kidney function to rule out CKD-related secondary hyperparathyroidism 2

If serum 25-hydroxyvitamin D is <30 ng/mL, initiate supplementation with vitamin D (ergocalciferol or cholecalciferol), as recommended by the American Journal of Kidney Diseases 3
Dosing should be based on the severity of deficiency, with higher doses required for severe deficiency (<5 ng/mL) 4
Target serum 25-hydroxyvitamin D levels >30 ng/mL 3
Calcium citrate may be preferred over calcium carbonate in patients with suspected malabsorption, according to Nature Reviews Nephrology 5
Avoid giving calcium supplements together with high phosphate foods as this may reduce absorption 5

Once vitamin D repletion is achieved, continue supplementation with a vitamin D-containing multivitamin and reassess 25-hydroxyvitamin D levels annually, as recommended by the American Journal of Kidney Diseases 3
Continue monitoring serum calcium and phosphorus every 3 months 3
For patients with malabsorption, more frequent monitoring may be necessary 6

In patients with malabsorption syndromes, higher doses of vitamin D and calcium may be required, according to Metabolism: Clinical and Experimental 6
Excessive calcium supplementation can lead to hypercalcemia and hypercalciuria, as noted in Nature Reviews Nephrology 5
Phosphate-rich foods and medications can impair calcium absorption and should be separated from calcium supplements 5